BRUSSELS (AP) — The European Union’s antitrust authority says it has approved the $5.4 billion sale of Novartis’ animal health division to U.S. pharmaceutical firm Eli Lilly.
The 28-nation bloc’s executive Commission said Friday the sale won’t hinder competition because the merged firm will continue to face a number of strong competitors.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.